Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Concept OB is a brand-name prenatal multivitamin and mineral supplement developed and marketed by U.S. Pharmaceutical Corporation. It is indicated for prenatal nutritional supplementation and to treat or prevent conditions such as iron deficiency and general nutritional deficiency during pregnancy. The formulation consists of a combination of essential vitamins and minerals, including vitamin C, vitamin B1 (thiamine mononitrate), vitamin B2 (riboflavin), vitamin B3 (niacin), folic acid, biotin, iron, magnesium, and zinc. It is formulated as a pink oral capsule and is available over-the-counter, though it is categorized by the FDA under the NDC labeler code 52747 as an 'unapproved drug other' product, a common classification for prenatal vitamins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Concept OB.